Currently the price is 11,64$, Iovance Biotherapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Frederick G. Vogt (President, CEO, Secretary & General Counsel), Friedrich Graf Finckenstein (Chief Medical Officer), Igor P. Bilinsky (Chief Operating Officer), Jean-Marc Bellemin (CFO & Principal Accounting Officer) and its address is 999 SKYWAY ROAD SUITE 150, SAN CARLOS, California, 94070, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 11,57$ moving between 11,34$ and 11,80$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
